US Stock MarketDetailed Quotes

ELVN Enliven Therapeutics

Watchlist
  • 22.570
  • +0.030+0.13%
Close May 31 16:00 ET
  • 22.570
  • 0.0000.00%
Post 16:07 ET
1.06BMarket Cap-13268P/E (TTM)

Enliven Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Enliven Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.54

+32.50%
Analyst Rating

Strong Buy

May 31, 2024

Enliven Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--------
--------
--------

Unlock Free Earnings Estimates

Enliven Therapeutics Earnings Reports

  • Enliven Therapeutics | 10-Q: Quarterly report

    May 14 16:23 ET

  • Enliven Therapeutics | 10-K: Annual report

    Mar 14 16:22 ET

  • Enliven Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:15 ET

  • Enliven Therapeutics | 10-Q: Quarterly report

    Aug 10, 2023 16:16 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 31, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg